Subscribe to this journal
Advanced Search
Share
Subscribe
COVID-19
Metrics
Editorial Board
Publish in this journal
Current Issue
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia
¿Por qué elegir ciclosporina A como primera línea terapéutica para la neumonía causada por COVID-19?
Olga Sanchez-Pernautea,
Corresponding author
osanchez@fjd.es

Corresponding author.
, Fredeswinda I. Romero-Buenoa, Albert Selva-O’Callaghanb
a Rheumatology Division, Jiménez Díaz Foundation University Hospital and Health Research Institute, Universidad Autónoma de Madrid, Madrid, Spain
b Department of Internal Medicine, Hospital Universitari Val d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
Read
48
Times
was read the article
4
Total PDF
44
Total HTML
0
Total EPUB
Share statistics
Article information
ISSN: 21735743
Original language: English
DOI:10.1016/j.reumae.2020.03.005
The statistics are updated each day
Year/Month Html Pdf Epub Total
2021 November 44 4 0 48
2021 October 0 0 0 0

Follow this link to access the full text of the article

Subscribe to our newsletter

Special content about COVID-19
Publish in
Reumatología Clínica
Idiomas
Reumatología Clínica (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?